Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (641-650 of 1,726) with videos related to

Pageof 173
Sort By:
Lancet (London, England)|June 16, 2007
New therapies for treatment of rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Marcus Koeller, et al.
Investigative Ophthalmology & Visual Science|November 1, 2011
New grading criteria allow for earlier detection of geographic atrophy in clinical trialsHilary Smolen Brader, Gui-Shuang Ying, E Revell Martin, et al.
Journal of Pharmaceutical Sciences|November 1, 1976
Pharmacokinetics of chlorpromazine-induced miotic response in rabbitsP B Kuehn, A K Jhawar, W A Weigand, et al.
The Journal of Rheumatology|February 11, 1999
Outcome measures to be used in clinical trials in systemic lupus erythematosusV Strand, D Gladman, D Isenberg, et al.
Rheumatology (Oxford, England)|March 25, 2004
Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritisV Strand, S Cohen, B Crawford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1982
The human autologous mixed lymphocyte reaction. III. Immune circuitsJ S Smolen, T M Chused, E A Novotny, et al.
Arthritis and Rheumatism|October 2, 2007
Mapping hand functioning in hand osteoarthritis: comparing self-report instruments with a comprehensive hand function testTanja Stamm, Mona Mathis, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|August 31, 2007
Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysisM Bonelli, K von Dalwigk, A Savitskaya, et al.
Arthritis and Rheumatism|August 29, 2009
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivoRoland Axmann, Christina Böhm, Gerhard Krönke, et al.
Arthritis and Rheumatism|December 30, 2006
Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritisSilvia Hayer, Kurt Redlich, Adelheid Korb, et al.
Pageof 173

Showing results (641-650 of 1,726) with videos related to

Sort By:
Pageof 173
Lancet (London, England)|June 16, 2007
New therapies for treatment of rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Marcus Koeller, et al.
Investigative Ophthalmology & Visual Science|November 1, 2011
New grading criteria allow for earlier detection of geographic atrophy in clinical trialsHilary Smolen Brader, Gui-Shuang Ying, E Revell Martin, et al.
Journal of Pharmaceutical Sciences|November 1, 1976
Pharmacokinetics of chlorpromazine-induced miotic response in rabbitsP B Kuehn, A K Jhawar, W A Weigand, et al.
The Journal of Rheumatology|February 11, 1999
Outcome measures to be used in clinical trials in systemic lupus erythematosusV Strand, D Gladman, D Isenberg, et al.
Rheumatology (Oxford, England)|March 25, 2004
Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritisV Strand, S Cohen, B Crawford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1982
The human autologous mixed lymphocyte reaction. III. Immune circuitsJ S Smolen, T M Chused, E A Novotny, et al.
Arthritis and Rheumatism|October 2, 2007
Mapping hand functioning in hand osteoarthritis: comparing self-report instruments with a comprehensive hand function testTanja Stamm, Mona Mathis, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|August 31, 2007
Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysisM Bonelli, K von Dalwigk, A Savitskaya, et al.
Arthritis and Rheumatism|August 29, 2009
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivoRoland Axmann, Christina Böhm, Gerhard Krönke, et al.
Arthritis and Rheumatism|December 30, 2006
Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritisSilvia Hayer, Kurt Redlich, Adelheid Korb, et al.
Pageof 173